Dimensional Changes in Lipid Rafts from Human Brain Cortex Associated to Development of Alzheimer's Disease....

Area of Science:

• Neuroscience
• Biochemistry
• Computational Biology

Background:

• Alzheimer's disease (AD) is a neurodegenerative disorder characterized by protein aggregates in the brain, with aging as the primary risk factor.
• Lipid rafts, crucial membrane microdomains, are implicated in AD pathogenesis, particularly in amyloid-beta peptide aggregation.
• Alterations in lipid raft composition and properties precede clinical symptoms in early AD neuropathology.

Purpose of the Study:

• To model the dimensional evolution of lipid rafts in Alzheimer's disease using experimental data.
• To investigate the relationship between lipid raft changes and disease progression stages.
• To explore the link between lipid raft alterations, oxidative stress, and AD neuropathology.

Main Methods:

• Utilized coarse-grain molecular dynamics simulations.
• Employed experimental data from human frontal cortex.
• Analyzed changes in lipid raft size and frequency across AD neuropathological stages.

Main Results:

• Predicted significant changes in lipid raft size and frequency detectable at early AD stages (ADI/II).
• Observed fewer, larger lipid rafts in advanced AD stages (ADV/VI).
• Identified simultaneous alterations in non-raft membrane peroxidability, suggesting a link to oxidative stress.

Conclusions:

• Lipid raft dimensional changes are early indicators of Alzheimer's disease.
• Synergistic alterations in lipid rafts and non-rafts contribute to AD progression.
• These changes may form a positive feedback loop exacerbating amyloid burden and neuronal death in AD.